Bioteque Corporation (4107.TWO)
- Previous Close
125.50 - Open
124.50 - Bid 124.50 x --
- Ask 125.50 x --
- Day's Range
124.50 - 125.50 - 52 Week Range
101.00 - 147.50 - Volume
24,607 - Avg. Volume
116,739 - Market Cap (intraday)
8.662B - Beta (5Y Monthly) 0.22
- PE Ratio (TTM)
16.21 - EPS (TTM)
7.71 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield 5.00 (3.98%)
- Ex-Dividend Date Jul 28, 2025
- 1y Target Est
--
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company provides medical disposables for use in hemodialysis access, endovascular treatment, and other fields. It offers dialysis products, including hemodialysis bloodlines, A.V.F. needles, and hemodialysis cathers; interventional radiology products, such as pigtail drainage catheter sets, introducer sets, connecting tubes, drainage bags, and radiopaque dilators; urology products comprising ureteral stent sets and urine collection bags; and IV administration products, such as PVC IV infusion bags, PVC bags, and twist-off ports. In addition, the company provides respiratory care products, such as closed suction catheters and endotracheal tubes; vascular access products comprising angiographic catheters, PTA balloon dilatation catheters, sheath introducers, guidewires, high pressure connecting tubes, PTCA balloon dilatation catheter-rapid exchange products, manifolds, and Y connectors; and medical components, including dialyzer connectors and caps, recirculating connectors with cap, rotating luer lock connectors, pump and T connectors, female luers, injection sites, luer lock and chamber caps, drip chambers, filters, clamps, pressure pillows, safeline HDF components, chamber assembly, and transducer protectors, as well as medical masks. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.
www.bioteq.com.twRecent News: 4107.TWO
View MorePerformance Overview: 4107.TWO
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4107.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4107.TWO
View MoreValuation Measures
Market Cap
8.70B
Enterprise Value
7.65B
Trailing P/E
16.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.18
Price/Book (mrq)
2.69
Enterprise Value/Revenue
3.65
Enterprise Value/EBITDA
8.84
Financial Highlights
Profitability and Income Statement
Profit Margin
25.64%
Return on Assets (ttm)
8.68%
Return on Equity (ttm)
17.15%
Revenue (ttm)
2.09B
Net Income Avi to Common (ttm)
537.11M
Diluted EPS (ttm)
7.71
Balance Sheet and Cash Flow
Total Cash (mrq)
1.75B
Total Debt/Equity (mrq)
16.84%
Levered Free Cash Flow (ttm)
613.52M